Results 21 to 30 of about 1,981 (114)
BMJ, 2009 Lifestyle modification, drug treatment, and evidence based discussion about further interventions are ...
Yusuf, S +3 more
openaire +3 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022 Background There are limited data about how COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) and ORBITA (Objective Randomized Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina) trials
Muhammad Rashid +9 more
doaj +1 more source
Journal of Pharmacopuncture, 2022 Objectives: Routine therapies cannot control refractory stable angina, leading to a high economic burden and an impaired quality of life. Persian medicine incorporates exceptional attention to lifestyle and nutrition to prevent and treat various diseases.
Mohammad Abazari +5 more
doaj +1 more source
Архивъ внутренней медицины, 2014 In patients with symptoms of stable angina coronary angiography often fails to reveal significant atherosclerosis. So far as prognosis in these patients is better than in patients with significant coronary atherosclerosis (SCA) the factors associated ...
Е. И. Ярославская +5 more
doaj +1 more source
CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA
Рациональная фармакотерапия в кардиологии, 2016 Aim. To study efficacy of testosterone undecanoate (TU) therapy in men with stable angina and androgen deficiency.Material and methods. The serum testosterone level was detected in 247 men (aged 51,6±1,8 y.o.) with stable effort angina.
A. Ya. Kravchenko, V. M. Provotorov
doaj +3 more sources
The Professional Medical Journal, 2009 Objective: To see the frequency of coronary artery stenosis in the patients of stable angina having left bundle branchblock, and to see the effects of gender and age on this correlation. Design: Experimental case series. Setting: Bahawal Victoria Hospital,Bahawalpur. Period: June 2006 to May 2008.
SHAFIQUE AHMED +3 more
openaire +2 more sources
Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives
Кардиоваскулярная терапия и профилактика, 2012 The review discusses the benefits and various practical aspects of the new cardioprotector mildronate use in cardiology. The latest evidence on the mildronate role in complex therapy of patients with stable angina, or patients in the rehabilitation ...
V. P. Mikhin +3 more
doaj +1 more source
Frontiers in Cardiovascular MedicineObjectiveIn this study, we aimed to compare the levels of inflammatory markers (C-reactive protein, CRP; procalcitonin, PCT) and blood lipids (total cholesterol, TC; triglyceride, TG; high-density lipoprotein cholesterol, HDL-C; low-density lipoprotein ...
Lei Xiang
doaj +1 more source
Cardiology and Therapy, 2020 Introduction Trimetazidine (TMZ) is an antianginal agent that acts directly at the myocardial cell level and which is now available in a once-daily (od) formulation.
Maria G. Glezer +2 more
doaj +1 more source
Ranolazine for stable angina pectoris [PDF]
Cochrane Database of Systematic Reviews, 2015 Stable angina pectoris is a chronic medical condition with significant impact on mortality and quality of life; it can be macrovascular or microvascular in origin. Ranolazine is a second-line anti-anginal drug approved for use in people with stable angina.
Carlos A, Salazar +5 more
openaire +2 more sources